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Abstract:Primary Acinic Cell Carcinoma (ACC) is an uncommon salivary gland (SG) tumor, 
making up 1% of all SG neoplasms. The parotid is the most common topography, and the 
ACCs are more frequently diagnosed in the fourth to sixth decades of life. In this study, 
along with a brief review of the literature, we discussed the clinical, histopathological, and 
prognostic features of these SG tumors through three reported cases. All of the tumors 
occurred in left parotid of non-smoking and non-drinking white patients, aging 80, 51, and 56 
years. The lesions were painless and presented as slow-growing, large, firm, and movable 
solitary masses in the left mandible angle. The patients were initially submitted to a clinical, 
radiographic and computed tomography exam, followed by fine-needle aspiration and an 
excisional biopsy to confirm the diagnosis. All of the patients were treated with surgery 
followed by radiotherapy. Two of the patients had a local recurrence, one of which had 
cervical lymph node involvement, but both are still alive. The other patient did not have a 
local recurrence or lymph node involvement, but developed distant pulmonary metastases 
and died. The follow-up times were 18, 102 e 22 (with death) months. Upon histopathological 
analysis, ACC typically shows a solid pattern of growth, with cells exhibiting serous acinar cell 
differentiation and cytoplasmic basophilic granules. Complete surgical resection is the usual 
therapeutic choice. The literature describes ACC as a tumor with low malignant potential, 
but several recurrences and metastasis have been reported, as verified in the present study.
Resumo: O Carcinoma de Células Acinares (CCA) é um tumor incomum das glândulas 
salivares (GS), perfazendo 1% de todas as neoplasias de GS. A parótida é a localização 
mais comum, e os CCAs são mais frequentemente diagnosticados entre a quarta e sexta 
décadas. No presente estudo, junto com uma breve revisão da literatura, foram discuti-
das as características clínicas, histopatológicas e prognósticas destes tumores através 
do relato de três casos. Todos os tumores ocorreram na glândula parótida esquerda de 
pacientes leucodermas, não fumadores e sem hábitos de bebida, com idades de 80, 51 e 56 
anos. As lesões eram assintomáticas e apresentaram-se como uma grande massa única 
de crescimento lento, endurecida e móvel,  no ângulo mandibular esquerdo. Os pacientes 
foram inicialmente submetidos aos exames clínico, radiográfico e tomográfico, seguidos 
de aspiração por agulha fina e biópsia excisional para confirmação do diagnóstico. Todos 
os pacientes foram tratados com cirurgia seguida de radioterapia. Dois pacientes tiveram 
recidivas, um deles com envolvimento de linfonodos cervicais, porém ambos ainda estão 
vivos. O outro paciente não apresentou recidiva ou envolvimento linfonodal, mas desen-
volveu metástases pulmonares e foi a óbito. Os tempos de acompanhamento foram de 18, 
102 e 22 (com óbito) meses. Ao exame histopatológico, os CCAs demonstraram um típico 
padrão de crescimento sólido, com células exibindo diferenciação acinar serosa e grânulos 
basofílicos no citoplasma. A ressecção cirúrgica completa é a opção terapêutica usual. 
A literatura descreve o CCA como um tumor de baixo potencial de malignidade, porém, 
diversas recorrências e metástases tem sido relatadas, como verificado no presente estudo.
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Salivary gland (SG) tumors represent 3% of all neoplasms 
of the head and neck. Primary acinic cell carcinoma (ACC) of 
the SG is a clinically low-grade malignancy that comprises 1% 
of all SG neoplasms, 5 to 11% of malignant SG tumors, and 
approximately 12.5% of parotid gland carcinomas(1-3).
In SG topography, up to 81 to 98% of ACC cases occur in 
the parotid gland. ACC rarely originates in the submandibular 
gland and only a few cases were reported in the minor SG 
of the oral cavity(4,5). ACC typically presents as slow growing 
masses in middle-aged patients (5th and 6th decades of life). 
It is slightly more common in women than men(2,3,6,7).
Due to its indolent behavior, ACC was thought to be a 
benign neoplasm until 1953, when it was finally considered to 
be malignant(8,9). In 1972, the World Health Organization (WHO) 
proposed the categorization of the acinic cell neoplasms in the 
WHO’s International Classification of Diseases for Oncology 
(ICD-O) as “acinic cell tumors”, separate from undoubtedly 
benign or malignant neoplasms. Currently, the more recent 
ICD-O (ICD-10) confirms these neoplasms as true adeno-
carcinomas(10).
Considering that ACC is an uncommon malignant 
neoplasm, there are still limited data concerning its clinical, 
histopathological, and prognostic features. Along with a brief 
review of the literature, this study aims to broad our unders-
tanding of primary ACCs of the parotid glands through the 
description of three cases.
Patient 1
An 80-year-old non-smoking and non-drinking white 
female arrived at the General Hospital of Ribeirao Preto 
School of Medicine (GHRPSM) complaining of a painless 
swelling at the left mandible angle, in the parotid gland topo-
graphy. The initial swelling had been observed six months 
earlier, but grew quite quickly in the past three weeks. On 
clinical examination, the tumoral lesion presented as a large, 
firm, and freely movable mass in the left mandible angle, 
which was 3 cm in diameter. No pain or facial palsy was 
associated. The patient was initially submitted to a clinical, 
radiographic, and computed tomography (CT) exam (Figure 
1), and a fine-needle aspiration biopsy (FNAB) was perfor-
med with inconclusive cytological findings. As the lesion was 
localized in the superficial parotid lobe, it was excised by a 
superficial parotidectomy that spared the facial nerve, follo-
wed by postoperative radiotherapy. The histopathological 
exam confirmed the diagnosis of ACC. The slides stained by 
hematoxylin and eosin showed a solid-cystic neoplasm with 
serous acinar differentiation intermingled with a lymphoid 
infiltrate, composed by some enlarged rounded cells with 
hyperchromatic and eccentric nuclei and a basophilic granu-
lar cytoplasm (Figure 2). In addition, some scattered clear, 
vacuolated, and intercalated duct cells also were present. 
The cytoplasmic granules were PAS positive, and diastase 
resistant. There was a local recurrence 10 months after the 
initial diagnosis, but there was no local or distant metastasis. 
The patient is still alive 18 months after the diagnosis. 
Patient 2
A 51-year-old non-smoking and non-drinking white male 
arrived at GHRPSM with a three month history of a slow 
growing painless lump on the left side of his face. On palpa-
tion, a firm, painless, irregular, and freely movable nodule, 
that was 15 cm in diameter, was detected in the parotid, 
INTRODUCTION
CASE REPORT
Figure 1 - Preoperative anteroposterior tomographic exam demonstrating 
a large mass in the left face.
Figure 2 - Microscopic features of the tumor. Tumor showing serous acinar 
differentiation characterized by small glands composed of polygonal cells 
with round and eccentric nuclei, and a basophilic granular cytoplasm (hematoxylin-
eosin, x200).
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beside a cervical nodule that was 1 cm in diameter. He had 
a previous history of a resected ACC in the left parotid gland. 
After a clinical exam, the patient underwent radiographic 
and CT exams (Figure 3), and then a FNAB was performed 
to confirm the hypothesis of ACC. The cytological analysis 
showed highly cellular smears composed by grouped structu-
res or isolated cells. The cells showed a round or oval nuclei, 
few nucleoli, and a granular basophilic cytoplasm. There were 
abundant psammoma bodies (PBs) with concentric lamina-
tion (Figure 4). Total parotidectomy with left cervical emptying 
and coadjuvant radiotherapy was performed. The histopa-
thological exam disclosed a tumor with cells surrounded by a 
prominent desmoplastic stromal reaction. It also confirmed the 
lymph nodal involvement. The patient had a local recurrence 58 
months after the initial histopathological diagnosis, but he had 
no additional lymph node involvement or distant metastasis in 
an overall follow-up of 102 months. He is still alive. 
Patient 3
A 56-year-old non-smoking and non-drinking white 
woman arrived at GHRPSM complaining of a progressive 
swelling in the left preauricular region. She had first noted this 
swelling three months earlier. Clinical examination showed 
a firm, mobile, painless, and well-defined nodule in the left 
parotid topography measuring 5 cm in diameter. Clinical, 
radiographic, CT, and FNAB exams were preformed. All of 
them were indicative of malignancy. Since the lesion was loca-
lized in the deep lobe of the parotid gland, it was surgically 
removed through a total parotidectomy. The diagnosis of ACC 
was confirmed by the histopathological exam, and then the 
patient underwent postoperative radiotherapy. Within the first 
year of follow-up, no local recurrence or cervical lymph node 
involvement was noted, but immediately after this period, 
she developed distant pulmonary metastases diagnosed 
by a chest radiographic exam. The pulmonary metastases 
presented as several irregular nodules with diffuse margins 
localized predominantly in the lower region (Figure 5). After 
that, the patient died of respiratory failure, 22 months after 
the initial diagnosis.
ACC is considered to be the least aggressive cancer of 
SGs(3,11); however, the WHO recognizes it’s potential to behave 
in an aggressive manner (10). In head and neck topography, 
ACC is usually found in the parotid gland and appears as a 
slow growing tumor, with no classical clinical features distin-
guishing it from other SG lesions(12).
Despite being considered a low-grade neoplasm with 
an indolent clinical course,13 secondary tumors can appear 
within five years of the diagnosis in 82% of the cases(5). The 
recurrence rate for these tumors ranges from 30% to 50%(6), 
and when the deep lobe of the parotid gland is reached, local 
DISCUSSION
Figure 3 - Preoperative axial computed tomography image showing a well-
circumscribed mass in left parotid gland (asterisk). 
Figure 5 - Radiographic exam showing pulmonary metastases presented as 
irregular nodules with diffuse margins and scattered distribution. They are 
predominantly localized in the lower region of the lungs.
Figure 4 - Fine-needle aspiration biopsy smears disclosing numerous psam-
moma bodies (Papanicolaou, x200).
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recurrences are higher than in superficial tumors (72% and 
18%, respectively)(14). Additionally, the cervical metastases 
rate ranges from 3.8-16%(3,5), distant metastases have been 
reported between 7%-29%(15), and the death rate due ACC 
varies from 1.3% to 26%(3,5,16).
Most investigations have noticed that women are affec-
ted more frequently than men, and that ACC happens at an 
earlier age than other SG tumors(4,15). Most cases are unilate-
ral(15); however, there was a single report of bilateral parotid 
involvement(8).
In ACCs, clinicopathologic characteristics can be very 
important to predict the patients outcome, especially tumor 
size(6,14,16,17), compromised surgical margins(5,14,17,18), and involve-
ment of the deep lobe of the parotid gland(5,16). Age, histological 
grade, and the presence of metastatic disease have also been 
considered significant prognostic factors(3). As a consensus, 
regional and distant metastases are given a poor prognosis, 
while the lungs and bones are the most preferable sites for 
ACC dissemination(13,14,15).
Some authors initially believed that ACC could originate 
from the acini(19). However, it has been suggested that the 
multiple morphological growth patterns of ACC are possibly 
due its origin from stem or reserve epithelial cells found at 
the intercalated ducts and terminal tubules, which could be 
precursor cells for both acini and duct cells of the mature 
SG tissue(20). The main histopathological feature for ACC diag-
nosis is the identification of neoplastic acinar cells forming solid 
or microcystic areas, which are the most common growth 
patterns(2,21). Sometimes it is possible to discern some other 
neoplastic acinar cells, such as oncocytic and vacuolated cells(12).
The term “acinic” denotes similarity of the tumor cells 
with acinar gland cells. In a microscopic point of view, ACC 
can show acinar differentiation and is composed of neoplastic 
acini and duct-like cells, often ordered in a solid pattern, and 
generally with a dense lymphoid stroma(22,23). The tumor cells 
are polygonal and have a fine granular cytoplasm with a baso-
philic or amphophilic aspect, and these cytoplasmic granules 
are characteristically PAS positive and diastase-resistant(7). 
Moreover, primary ACC can demonstrate distinct histopatho-
logical patterns and frequently exhibit combinations of them: 
solid, follicular, microcystic, and papillary-cystic(5).
There is no specific immunohistochemical profile speci-
fically associated with these tumors. In that way, immuno-
histochemistry is not very useful to distinguish ACCs from 
other SG tumors. This technique normally is not required 
for diagnosis(2,7,15).Some studies postulated that electron 
microscopy could be helpful in certain cases(4). The ultras-
tructural characteristic of cells with acinar differentiation, the 
existence of a rough endoplasmic reticulum, and round to 
ovoid electron-dense granules in cytoplasm analogous to the 
zymogen granules of normal serous cells can be considered 
as diagnostic evidence(4,24).
The cytologic interpretation of an FNAB exam can be a 
difficult task due to the heterogeneity of the SG tumors, and, 
among the SG, one of the highest false negative rates occurs 
in ACCs(25). Because of the heterogeneous cytological presen-
tation of ACC, the smears were conclusive in only one of our 
three cases (Patient 2). However, the FNAB exam was useful 
to distinguish between a benign or malignant neoplasm in the 
other case (Patient 3). In all cases, it was the histopathological 
exam that provided the confirmation of the ACC diagnosis.
The abundant PBs found in the ACC smears of Patient 2 
have rarely been described. The PBs are concentric lamella-
ted calcified structures presented as basophilic concretions. 
They have been associated with dystrophic calcification of 
dead or dying tissue, but their physiopathology remains 
poorly understood(26). Since the first description by Bottles 
and Löwhagen in 1985(27), only a few cases of PBs in FNAB 
specimens of ACCs have been described in the English lite-
rature(28,29,30). Notwithstanding, PBs were reported in several 
others SG neoplasms, such as adenoid cystic carcinoma(31), 
oncocytic adenocarcinoma(32), salivary duct carcinoma(33), 
and some other benign and malignant mixed tumors(34,35). 
Recently, Das(26) suggested that PBs can represent an acti-
ve biologic process associated with retardation of the tumor 
growth mechanism, also capable of serving as a barrier 
against the neoplasm dissemination.
The association between tumor grade and biologic beha-
vior remains controversial. ACC can be classified as both 
low- or high-grade tumors. Low-grade ACCs are generally 
interpreted as corresponding to the architecture of normal 
salivary acini. They are encapsulated and measure less than 
3 cm. On the other hand, high-grade ACC resembles the early 
phases of acini embryonic development and are poorly diffe-
rentiated(20). Several studies indicate that high histopatholo-
gical grade is a key feature for the identification of a subset 
of ACCs with aggressive behavior(2,3,6,36). However, there are 
reports contradicting this association(4,15,37,38). In addition to low- 
or high-grade tumors, a few cases of dedifferentiated ACCs 
have been reported(18,39,40,41). These dedifferentiated tumors 
typically present as a recurrent disease(41). Albeit a single 
histopathological pattern usually prevails, mixed grades may 
occur within a single tumor(18).
The pulmonary metastases of Patient 3, detected one 
year after initial diagnosis of ACC, could be concomitant 
with the primary tumor. However, scarce cases are docu-
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mented in the literature of primary ACCs concurrently with 
lung metastases(13,42-44) Hynes et al(44) reported a rare case of 
a primary ACC in the submandibular gland simultaneous to 
pleural involvement. 
Distant metastases in ACCs tend to occur five to 30 years 
after primary diagnosis(13,15). However, lower intervals have 
been found, as in case reported by Vidyadhara et al(5) where the 
metastases in both lungs and thoracic vertebra were found 
after only four months of an incomplete primary surgical 
tumor resection. Cohn et al(45) report a case of an ACC with 
a distant metastasis to the bone, lung, and skin after only 
two years from the initial diagnosis. Moreover, Tavora et al(13) 
reported an unusual case of lung metastases one year befo-
re to the diagnosis of an occult primary ACC in the parotid 
gland. Although recurrences and metastases tend to occur 
after prolonged latency intervals(15), two of our patients had a 
recurrence and metastasis in a short period of time (Patient 
1 and Patient 3, respectively), and the other already presen-
ted with lymph nodal involvement in the first clinical referral. 
These data reinforce that some cases of ACC are potentially 
aggressive neoplasms.
Management of ACC is supported on some reports of 
small numbers of cases accumulated over several decades. 
According to Oliveira et al(38), the high recurrence rate seems 
to be predominantly determined by the surgical approach. 
Excision of cervical lymph nodes is indicated for those patients 
who have lym-phadenopathy(46). Postoperative radiotherapy 
has been recommended in patients with advanced clinical 
stage, high-grade tumors, or positive surgical margins(20), and 
for some other factors such as verified in Patient 2 (recurrent 
tumor and deep lobe involvement)(15,17). Since ACC carries a 
significant morbidity with high recurrence and metastasis 
rates, some studies warn that this tumor, in contrast to most 
other SG malignant tumors, may not respond to postoperative 
radiotherapy(3,6,47).
The 5-year overall survival (OS) has been estimated to be 
about 83% in ACCs(3). However, due to differences in popula-
tions, staging, therapies, and follow-up extension, this estima-
tive can vary widely. Federspil et al(36) found a 5-year OS of 73% 
and Laskawi et al(6) found 64%. According to Miki et al(48), due 
to the slow growth pattern of ACC, survival analyses should 
be interpreted with a long follow-up period (10 to 20 years) to 
identify the true influence of ACC on extended survival.
In summary, we report three cases of ACC primary of 
the parotid gland. In one of them numerous psammoma 
bodies were found in cytological smears, which is a very 
rare finding. In another case, rapid pulmonary commitment 
from the primary ACC was verified. The literature describes 
ACC as a tumor with low malignant potential, but several 
recurrences and metastasis have been reported, as verified 
in the present study. Our reports suggest that ACCs can be 
aggressive neoplasms.
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